Dr. Andrea Lukes established CWRWC after completing 10 years at Duke University Medical Center. She received her bachelor’s degree in religion from Duke University, followed by a combined medical degree and master’s degree in statistics from Duke University. She then completed her ObGyn residency at UNC. While on faculty at DUMC, she co-founded and served as the Director of Gynecology for the Women’s Hemostasis and Thrombosis Clinic. She particip ... Read More
AI generated from recent verified patient reviews
Patients consistently praise Dr. Andrea Lukes and her welcoming staff for providing exceptional, personalized care in a professional, relaxing environment. Dr. Lukes is highly regarded for her compassionate bedside manner, thoroughness, and outstanding clinical expertise. She takes the time to listen attentively without rushing, explaining options clearly, and partnering with patients on customized treatment plans. Reviewers appreciate the minimal wait times, prompt attention to detail, and a supportive atmosphere where they feel treated like family. Overall, patients express the utmost trust and confidence in Dr. Lukes’s safe, knowledgeable, and deeply reassuring care.
Verified Patient Reviews for Andrea Lukes, MD
[Rating Only]
[Rating Only]
Quick and very thorough visit.
[Rating Only]
Dr. Lukes will listen to concerns and discuss reasons and solutions. Staff are always welcoming and supportive.
[Rating Only]
Office staff were friendly and professional. The physician was personable and very knowledgeable. It was easy to make an appointment.
Everyone was friendly and made my visit pleasant and efficient.
[Rating Only]
[Rating Only]
Dr. Andrea Lukes established CWRWC after completing 10 years at Duke University Medical Center. She received her bachelor’s degree in religion from Duke University, followed by a combined medical degree and master’s degree in statistics from Duke University. She then completed her ObGyn residency at UNC. While on faculty at DUMC, she co-founded and served as the Director of Gynecology for the Women’s Hemostasis and Thrombosis Clinic. She participated in research programs supported by the NIH and CDC, as well as conducting multiple industry sponsored FDA trials. She continues to actively consult with industry regarding development and implementation of research protocols, including communications and presentations to the FDA. She has participated in over 75 FDA approved clinical studies.